Loading the player...
Primary Care Cardiovascular Update
This presentation will cover recent cardiovascular trials, device development and protocol changes.
Objectives:
1. Discuss strategies for primary and secondary risk prevention
2. Understand recent study data regarding PCSK9 inhibitors and NOACs for prevention
3. Understand the background for indications for TAVR and LAA occluders as well as technical considerations during implantation
Statement of Accreditation
The Texas Osteopathic Medical Association (TOMA) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. TOMA designates is program for a maximum of 1 AOA Category 1-A credits and will report CME credits commensurate with the extent of the physician’s participation in this activity.
Grievance Policy
All grievances may be directed to TOMA's Executive Director at toma@txosteo.org. All grievances will receive an initial response within 30 days of receipt. If the participant does not receive a satisfactory response, they can submit a complaint to the Bureau of Osteopathic Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.
Dr. Anthony Agostini is a board certified interventional Cardiologist and has been practicing in Amarillo since June of 2007. He is a graduate of Penn State University and attended medical school at Lake Erie College of Osteopathic Medicine. Dr. Agostini completed both his Cardiology and Interventional Cardiology Fellowship at Temple University School of Medicine in Pittsburgh, PA. Prior to joining the Cardiology Center of Amarillo, Dr. Agostini was in private practice in Longview, Texas.
Dr. Agostini discloses that he has no relevant financial relationships with any organization producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients relative to the content of this presentation.
